SLC7A11 as a gateway of metabolic perturbation and ferroptosis vulnerability in cancer

J Lee, JL Roh - Antioxidants, 2022 - mdpi.com
SLC7A11 is a cell transmembrane protein composing the light chain of system xc−,
transporting extracellular cystine into cells for cysteine production and GSH biosynthesis …

Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy

P Koppula, L Zhuang, B Gan - Protein & cell, 2021 - academic.oup.com
The cystine/glutamate antiporter SLC7A11 (also commonly known as xCT) functions to
import cystine for glutathione biosynthesis and antioxidant defense and is overexpressed in …

[HTML][HTML] NADPH debt drives redox bankruptcy: SLC7A11/xCT-mediated cystine uptake as a double-edged sword in cellular redox regulation

X Liu, Y Zhang, L Zhuang, K Olszewski, B Gan - Genes & diseases, 2021 - Elsevier
Cystine/glutamate antiporter solute carrier family 7 member 11 (SLC7A11; also known as
xCT) plays a key role in antioxidant defense by mediating cystine uptake, promoting …

[HTML][HTML] SLC7A11/xCT in cancer: biological functions and therapeutic implications

W Lin, C Wang, G Liu, C Bi, X Wang… - American journal of …, 2020 - ncbi.nlm.nih.gov
Amino acid transporters mediate substrates across cellular membranes and their fine-tuned
regulations are critical to cellular metabolism, growth, and death. As the functional …

The role of cystine/glutamate antiporter SLC7A11/xCT in the pathophysiology of cancer

N Jyotsana, KT Ta, KE DelGiorno - Frontiers in oncology, 2022 - frontiersin.org
SLC7A11/xCT is an antiporter that mediates the uptake of extracellular cystine in exchange
for glutamate. Cystine is reduced to cysteine, which is a rate-limiting precursor in glutathione …

Disulfidptosis: disulfide stress–induced cell death

X Liu, L Zhuang, B Gan - Trends in Cell Biology, 2023 - cell.com
The cystine transporter solute carrier family 7 member 11 (SLC7A11)(also known as xCT)
promotes glutathione synthesis and counters oxidative stress–induced cell death, including …

The N6‐methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma

L Liu, J He, G Sun, N Huang, Z Bian… - Clinical and …, 2022 - Wiley Online Library
Background Solute carrier family 7 member 11 (SLC7A11) is overexpressed in multiple
human tumours and functions as a transporter importing cystine for glutathione biosynthesis …

Intra-tumoral expression of SLC7A11 is associated with immune microenvironment, drug resistance, and prognosis in cancers: a pan-cancer analysis

J He, H Ding, H Li, Z Pan, Q Chen - Frontiers in Genetics, 2021 - frontiersin.org
While many anti-cancer modalities have shown potent efficacy in clinical practices, cancer
prevention, timely detection, and effective treatment are still challenging. As a newly …

Super-enhancer-driven MLX mediates redox balance maintenance via SLC7A11 in osteosarcoma

W Guo, X Wang, B Lu, J Yu, M Xu, R Huang… - Cell Death & …, 2023 - nature.com
Osteosarcoma (OS) is a common type of bone tumor for which there has been limited
therapeutic progress over the past three decades. The prevalence of transcriptional …

SLC7A11/xCT is a target of miR-5096 and its restoration partially rescues miR-5096-mediated ferroptosis and anti-tumor effects in human breast cancer cells

P Yadav, P Sharma, S Sundaram, G Venkatraman… - Cancer letters, 2021 - Elsevier
Breast cancer cells evade cell death by overexpressing SLC7A11, which functions by
transporting cystine into cells in exchange for intracellular glutamate facilitating glutathione …